Orthopaedic Hospital, Department of Orthopaedic Surgery, University of California at Los Angeles (UCLA), CA, USA.
Blood. 2013 Apr 11;121(15):2891-901. doi: 10.1182/blood-2012-08-451864. Epub 2013 Feb 14.
Hematopoietic stem and progenitor cells (HSPCs) emerge and develop adjacent to blood vessel walls in the yolk sac, aorta-gonad-mesonephros region, embryonic liver, and fetal bone marrow. In adult mouse bone marrow, perivascular cells shape a "niche" for HSPCs. Mesenchymal stem/stromal cells (MSCs), which support hematopoiesis in culture, are themselves derived in part from perivascular cells. In order to define their direct role in hematopoiesis, we tested the ability of purified human CD146(+) perivascular cells, as compared with unfractionated MSCs and CD146(-) cells, to sustain human HSPCs in coculture. CD146(+) perivascular cells support the long-term persistence, through cell-to-cell contact and at least partly via Notch activation, of human myelolymphoid HSPCs able to engraft primary and secondary immunodeficient mice. Conversely, unfractionated MSCs and CD146(-) cells induce differentiation and compromise ex vivo maintenance of HSPCs. Moreover, CD146(+) perivascular cells express, natively and in culture, molecular markers of the vascular hematopoietic niche. Unexpectedly, this dramatic, previously undocumented ability to support hematopoietic stem cells is present in CD146(+) perivascular cells extracted from the nonhematopoietic adipose tissue.
造血干细胞和祖细胞 (HSPCs) 于卵黄囊、主动脉-性腺-中肾区、胚胎肝脏和胎儿骨髓的血管壁附近出现并发育。在成年小鼠骨髓中,血管周细胞形成了 HSPCs 的“龛位”。在培养中支持造血的间充质干细胞/基质细胞(MSCs)本身部分来源于血管周细胞。为了确定它们在造血中的直接作用,我们测试了与未分馏的 MSCs 和 CD146(-)细胞相比,纯化的人 CD146(+)血管周细胞在共培养中维持人 HSPCs 的能力。CD146(+)血管周细胞通过细胞间接触,至少部分通过 Notch 激活,支持能够植入原发性和继发性免疫缺陷小鼠的人骨髓淋巴样 HSPCs 的长期持续存在。相反,未分馏的 MSCs 和 CD146(-)细胞诱导分化并损害 HSPCs 的体外维持。此外,CD146(+)血管周细胞表达血管造血龛位的分子标记,无论是在天然状态下还是在培养中。出乎意料的是,这种支持造血干细胞的显著、以前未被记录的能力存在于从非造血脂肪组织中提取的 CD146(+)血管周细胞中。